Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
- MVT
top of page
Search
Recent Posts
See AllMicrovascular Therapeutics selected as a Participant in the 2024 Landmark Venture Forum [Tucson, AZ] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company pioneering the developmen
2950
[Tucson, Arizona] – [2/05/2024] – Microvascular Therapeutics Inc. (MVT), a clinical-stage biotech company at the forefront of developing the next generation of microbubbles unlocking the therapeutic p
690
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the prestigious H7 Healthcare Accelerator
2660
bottom of page